217 results on '"Biomedical laboratories -- Reports"'
Search Results
2. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Nov. 20, 2020)
3. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Nov. 13, 2020)
4. Miragen Therapeutics, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 12, 2020)
5. Cancer Genetics, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 12, 2020)
6. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Nov. 12, 2020)
7. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Nov. 10, 2020)
8. Data from Clinical Laboratory Provide New Insights into Experimental Autoimmune Encephalomyelitis (Amifostine ameliorates induction of experimental autoimmune encephalomyelitis: Effect on reactive oxygen species/NLRP3 pathway)
9. Reports from University of Milan Highlight Recent Findings in Laboratory Hematology [International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13]
10. Investigators at Center for Clinical Laboratory Report New Data on Cancer (Advances in the role of m6A RNA modification in cancer metabolic reprogramming)
11. Studies Conducted at Department of Clinical Laboratory on Breast Cancer Recently Reported (MiR-27a Facilitates Breast Cancer Progression via GSK-3b)
12. Miragen Therapeutics, Inc. Files SEC Form 8-K/A, Current Report: (Oct. 1, 2020)
13. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Oct. 5, 2020)
14. Findings on Cancer Reported by Researchers at National Cancer Center Hospital East (Impact of DNA integrity on the success rate of tissue-based next-generation sequencing: Lessons from nationwide cancer genome screening project SCRUM-Japan ...)
15. Researchers from Department of Clinical Laboratory Report Findings in Beta Thalassemia [Rare double heterozygosity for poly A(A> G) and CD17(A> T) of beta thalassemia intermedia in a Chinese family]
16. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Sept. 24, 2020)
17. Reports Outline Drug Testing and Analysis Findings from University of Utah (Evaluate the Comparability of Two Automated Liquid Handling Systems for Clinical Toxicology Assays)
18. Patent Issued for Fluid Management And Patient Monitoring System (USPTO 10,779,756)
19. New Cervical Cancer Study Findings Recently Were Reported by Researchers at Department of Clinical Laboratory (MicroRNA-150 suppresses p27Kip1 expression and promotes cell proliferation in HeLa human cervical cancer cells)
20. Department of Clinical Laboratory Researchers Add New Data to Research in Cancer (miR-19 Is a Potential Clinical Biomarker for Gastrointestinal Malignancy: A Systematic Review and Meta-analysis)
21. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Sept. 15, 2020)
22. Researchers at Tianjin Medical Laboratory Report New Data on Spinal Muscular Atrophy (NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study)
23. Reports Summarize Clinical Laboratory Analysis Findings from University of Ulsan (Performance Evaluation of an Amplicon-based Next-generation Sequencing Panel Forbrca1andbrca2variant Detection)
24. Patent Issued for Electrode Lead (USPTO 10,751,143)
25. New Findings on Bladder Cancer Discussed by Researchers at Department of Clinical Laboratory (Serum LUCAT1 implicates the pathogenesis of muscle-invasive bladder cancer via targeting miR-199a-5p and miR-199b-5p)
26. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Aug. 20, 2020)
27. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Aug. 24, 2020)
28. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Aug. 14, 2020)
29. Cancer Genetics, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Aug. 13, 2020)
30. Study Findings on Antifungals Are Outlined in Reports from Department of Clinical Laboratory (Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical ...)
31. New Breast Cancer Study Findings Reported from Department of Clinical Laboratory (circCDYL Acts as a Tumor Suppressor in Triple Negative Breast Cancer by Sponging miR-190a-3p and Upregulating TP53INP1)
32. Recent Findings in Neurochemistry Described by Researchers from Department of Clinical Laboratory (EGb761 Protects Brain Microvascular Endothelial Cells Against Oxygen-Glucose Deprivation-Induced Injury Through lncRNA Rmst/miR-150 Axis)
33. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Jul. 24, 2020)
34. Studies from Department of Clinical Laboratory Yield New Information about Helicobacter pylori (Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance)
35. Data on Solid Cancer Detailed by Researchers at University of Cukurova (Integration of Liquid Biopsies Into Clinical Laboratory Applications Via Ngs In Cancer Diagnostics)
36. New Laboratory Medicine Findings Reported from Ewha Womans University (Verification of the Performance of the Bd Max Check-points Cpo Assay On Clinical Isolates)
37. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Jul. 2, 2020)
38. Cancer Genetics, Inc. Files SEC Form 10-Q/A, Quarterly Report [Sections 13 Or 15(D)]: (Jul. 6, 2020)
39. New Findings in Personalized Medicine Described from Department of Clinical Laboratory (Big data-driven precision medicine: Starting the custom-made era of iatrology)
40. Researchers from Medical College of Georgia Report Recent Findings in Benign Prostatic Hyperplasia (Promotion of Epithelial Hyperplasia By Interleukin-8-cxcr Axis In Human Prostate)
41. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Jun. 19, 2020)
42. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Jun. 23, 2020)
43. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Jun. 12, 2020)
44. Recent Findings from Dongguan Institute of Pediatrics Has Provided New Data on Clinical Laboratory Analysis (A novel nonsense mutation of ZEB2 gene in a Chinese patient with Mowat-Wilson syndrome)
45. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Jun. 1, 2020)
46. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (May 22, 2020)
47. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (May 7, 2020)
48. Miragen Therapeutics, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (May 8, 2020)
49. Researchers from Clinical Laboratories Detail Findings in Psoriasis (Circulating CD14+HLA-DR-/low Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome)
50. Recent Reports from Department of Clinical Laboratory Highlight Findings in Biological Regulators and Homeostatic Agents (MiR-20a promotes lung tumorigenesis by targeting RUNX3 via TGF-b signaling pathway)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.